Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Plos Pathogens|June 21, 2018
Correction: Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costsIvan Kosik, William L Ince, Lauren E Gentles, et al.Plos Pathogens|January 19, 2018
Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costsIvan Kosik, William L Ince, Lauren E Gentles, et al.The Journal of Experimental Medicine|January 27, 2019
Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodiesIvan Kosik, Davide Angeletti, James S Gibbs, et al.Journal of Virology|October 22, 2010
Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 virusesLindomar Pena, Amy L Vincent, Jianqiang Ye, et al.Cancer Letters|November 24, 2020
Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacyDiana Llopiz, Marta Ruiz, Leyre Silva, et al.Plos Pathogens|October 27, 2010
Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype?Jianqiang Ye, Erin M Sorrell, Yibin Cai, et al.Mbio|April 4, 2019
Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan LimitMeghan O Altman, Matthew Angel, Ivan Košík, et al.Influenza and Other Respiratory Viruses|June 15, 2011
Evidence of reassortment of pandemic H1N1 influenza virus in swine in Argentina: are we facing the expansion of potential epicenters of influenza emergence?Ariel Pereda, Agustina Rimondi, Javier Cappuccio, et al.Nature Immunology|February 14, 2017
Defining B cell immunodominance to virusesDavide Angeletti, James S Gibbs, Matthew Angel, et al.Nature Biotechnology|August 13, 2013
MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studiesRyan A Langlois, Randy A Albrecht, Brian Kimble, et al.Pageof 4